Fingerprint
Dive into the research topics of 'Continuous versus 1-year fixed-duration nivolumab in previously treated advanced non-small-cell lung cancer: CheckMate 153'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Continuous versus 1-year fixed-duration nivolumab in previously treated advanced non-small-cell lung cancer: CheckMate 153
David M. Waterhouse, Edward B. Garon, Jason Chandler, Michael McCleod, Maen Hussein, Robert Jotte, Leora Horn, Davey B. Daniel, George Keogh, Ben Creelan, Lawrence H. Einhorn, Justin Baker, Samer Kasbari, Petros Nikolinakos, Sunil Babu, Felix Couture, Natasha B. Leighl, Craig Reynolds, George Blumenschein, Vijay Gunuganti
Research output: Contribution to journal › Article › peer-review
116
Scopus
citations